[DOI] [PMC free article] [PubMed] [Google Scholar] 33
Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production
GLP-1 medications such as Tirzepatide and Semaglutide work by reducing appetite, controlling cravings, improving fullness, and helping the body use energy more efficiently leading to steady, sustainable fat loss without restrictive diets or surgery
Could be a string of honest mistakes or perhaps more likely - the cheap folks he hires to write for him that arent physicians/medical researchers/etc are just doing a lousy job
The study authors did a commendable job bolstering the case that this was a good apples to apples comparison by first comparing only people getting new diabetes medication, then statistically controlling for a whole range of other sociodemographic factors (age, education, race/ethnicity, area-level income) and MANY baseline health characteristics and health behaviors
GLP-1 medications should always be used under the guidance of a licensed healthcare provider